Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human immune system, researchers have pursued a straightforward strategy for treating autoimmune diseases. By developing therapies that interfere with these receptors, scientists […]